xmlns:atom="http://www.w3.org/2005/Atom" xmlns:atom="http://www.w3.org/2005/Atom"

Article 2U.K.

For the purposes of this Regulation, the following definitions apply in addition to the definitions set out in [F1the Medical Devices Regulations 2002]:

(a)

‘cell’ means the smallest organised unit of any living form which is capable of independent existence and of replacement of its own substance in a suitable environment;

(b)

‘tissue’ means an organisation of cells, extra-cellular constituents or both;

(c)

‘derivative’ means a material obtained from animal tissue through one or more treatments, transformations or steps of processing;

(d)

‘non-viable’ means having no potential for metabolism or multiplication;

(e)

‘TSEs’ means all transmissible spongiform encephalopathies as defined in Article 3(1)(a) of Regulation (EC) No 999/2001 of the European Parliament and of the Council(1);

(f)

‘TSE infectious agents’ means unclassified pathogenic agents which are capable of transmitting TSEs;

(g)

‘reduction, elimination or removal’ means a process by which the number of TSE infectious agents is reduced, eliminated or removed in order to prevent infection or pathogenic reaction;

(h)

‘inactivation’ means a process by which the ability to cause infection or pathogenic reaction by TSE infectious agents is reduced;

(i)

‘source country’ means the country or countries in which the animal was born, has been reared and/or has been slaughtered;

(j)

‘starting materials’ means raw materials or any other product of animal origin out of which, or with the help of which, the devices referred to in Article 1(1) are produced.